BA
CME icon

Bridgewater Associates’s CME Group CME Stock Holding History

Bridgewater Associates’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-98,463
Closed -$20.7M – 712
2023
Q4 		$20.7M Buy
98,463
+32,660
+50% +$6.97M 0.12% 137
2023
Q3 		$13.2M Sell
65,803
-144,189
-69% -$28.7M 0.08% 188
2023
Q2 		$38.9M Sell
209,992
-92,063
-30% -$17M 0.24% 80
2023
Q1 		$57.8M Sell
302,055
-108,718
-26% -$19.7M 0.35% 58
2022
Q4 		$69.1M Buy
410,773
+92,510
+29% +$16.1M 0.38% 56
2022
Q3 		$56.4M Buy
318,263
+398
+0.1% +$78.7K 0.29% 74
2022
Q2 		$65.1M Buy
317,865
+185,464
+140% +$39.3M 0.28% 74
2022
Q1 		$31.5M Buy
+132,401
New +$31.1M 0.13% 123
2021
Q3 		– Sell
-3,998
Closed -$850K – 704
2021
Q2 		$850K Buy
3,998
+180
+5% +$38K 0.01% 605
2021
Q1 		$780K Buy
+3,818
New +$752K 0.01% 336
2019
Q3 		– Sell
-3,001
Closed -$583K – 342
2019
Q2 		$583K Sell
3,001
-17,301
-85% -$3.19M ﹤0.01% 253
2019
Q1 		$3.34M Buy
+20,302
New +$3.59M 0.02% 168
2018
Q4 		– Sell
-4,632
Closed -$788K – 481
2018
Q3 		$788K Buy
+4,632
New +$780K 0.01% 244
2018
Q1 		– Sell
-2,353
Closed -$344K – 467
2017
Q4 		$344K Sell
2,353
-6,363
-73% -$906K ﹤0.01% 232
2017
Q3 		$1.18M Sell
8,716
-1,661
-16% -$210K 0.01% 209
2017
Q2 		$1.3M Buy
10,377
+5,035
+94% +$602K 0.01% 196
2017
Q1 		$635K Buy
5,342
+842
+19% +$101K 0.01% 210
2016
Q4 		$519K Sell
4,500
-5,400
-55% -$601K ﹤0.01% 244
2016
Q3 		$1.03M Buy
+9,900
New +$1.03M 0.01% 223
2014
Q1 		– Sell
-74,868
Closed -$5.87M – 353
2013
Q4 		$5.87M Buy
74,868
+36,788
+97% +$2.88M 0.05% 92
2013
Q3 		$2.81M Buy
38,080
+8,469
+29% +$624K 0.02% 144
2013
Q2 		$2.25M Buy
+29,611
New +$1.94M 0.02% 149

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Bridgewater Associates's CME Position: Q1 2024 in Review

Bridgewater Associates sold out of CME Group (CME) in Q1 2024, closing a stake of 98,463 shares — an estimated $20.7M sold.

Bridgewater Associates first reported a position in CME in Q2 2013 and held it in 22 quarters. The position peaked at $69.1M in Q4 2022. 1,376 funds tracked by Wall St. Rank hold CME as of Q1 2024.

  • Bridgewater Associates reported no remaining CME Group position as of Q1 2024 after selling out during the quarter.
  • Bridgewater Associates sold 98,463 CME Group shares in Q1 2024, an estimated $20.7M.
  • Bridgewater Associates first reported a position in CME Group in Q2 2013 and held it in 22 quarters.
  • Bridgewater Associates's CME Group position peaked at $69.1M in Q4 2022.
  • 1,376 funds tracked by Wall St. Rank held CME Group as of Q1 2024.

Based on Bridgewater Associates's 13F filing for Q1 2024, filed 14 May 2024.